# BioDelivery Sciences International Inc. (BDSI)

Source: https://www.quantisnow.com/company/BDSI
Generated: 2026-11-16T17:52:48.680Z

- Ticker: BDSI
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Biotechnology: Pharmaceutical Preparations
- Website: bdsi.com

## About

BioDelivery Sciences International, Inc., a specialty pharmaceutical company, engages in the development and commercialization of pharmaceutical products for chronic conditions in the United States and internationally. The company provides its products based on its patented BioErodible MucoAdhesive drug-delivery technology, a small erodible polymer film for application to the buccal mucosa, as well as other drug-delivery technologies. It offers BELBUCA, a buprenorphine buccal film for the treatment of chronic pain; BUNAVAIL, a buprenorphine and naloxone buccal film to treat opioid dependence; and ONSOLIS, a fentanyl buccal soluble film for the management of breakthrough pain in cancer patients. The company also offers Symproic, a peripherally acting mu-opioid receptor antagonist for the treatment of opioid-induced constipation in adult patients with chronic non-cancer pain, including patients with chronic pain related to prior cancer or its treatment who do not require frequent opioid dosage escalation. BioDelivery Sciences International, Inc. was incorporated in 1997 and is headquartered in Raleigh, North Carolina.

## Latest BDSI news and filings

- 2023-02-10 21:14 UTC [SEC Schedule 13G] [SEC Form SC 13G/A filed by BioDelivery Sciences International Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13ga-filed-by-biodelivery-sciences-international-inc-4041652)
- 2022-10-24 11:30 UTC [Public Offering] [Genenta Provides First Half 2022 Business Update and Financial Results](https://www.quantisnow.com/insight/genenta-provides-first-half-2022-business-update-and-financial-results-3565235)
- 2022-04-27 11:30 UTC [Public Offering] [Genenta Announces Nomination of Mark A. Sirgo as Chair](https://www.quantisnow.com/insight/genenta-announces-nomination-of-mark-a-sirgo-as-chair-2775687)
- 2022-04-01 21:02 UTC [SEC Form 15-12B] [SEC Form 15-12B filed by BioDelivery Sciences International Inc.](https://www.quantisnow.com/insight/sec-form-15-12b-filed-by-biodelivery-sciences-international-inc-2667080)
- 2022-03-28 14:44 UTC [Market Insight] [Overview Of Value Stocks In The Healthcare Sector](https://www.quantisnow.com/insight/overview-of-value-stocks-in-the-healthcare-sector-2632456)
- 2022-03-28 04:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by BioDelivery Sciences International Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-biodelivery-sciences-international-inc-2630267)
- 2022-03-23 21:30 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by BioDelivery Sciences International Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-biodelivery-sciences-international-inc-2617200)
- 2022-03-23 21:30 UTC [SEC Form POS AM filed by BioDelivery Sciences International Inc.](https://www.quantisnow.com/insight/sec-form-pos-am-filed-by-biodelivery-sciences-international-inc-2617192)
- 2022-03-22 21:18 UTC [SEC Form 4] [SEC Form 4: Watson W. Mark disposed of 90,663 shares, closing all direct ownership in the company to satisfy tax liability](https://www.quantisnow.com/insight/sec-form-4-watson-w-mark-disposed-of-90663-shares-2610853)
- 2022-03-22 21:18 UTC [SEC Form 4] [SEC Form 4 filed by Vollins James (withholding tax)](https://www.quantisnow.com/insight/sec-form-4-filed-by-vollins-james-withholding-tax-2610848)
- 2022-03-22 21:17 UTC [SEC Form 4] [SEC Form 4: Singh Vanila disposed of 35,851 shares, closing all direct ownership in the company to satisfy withholding tax](https://www.quantisnow.com/insight/sec-form-4-singh-vanila-disposed-of-35851-shares-closing-2610839)
- 2022-03-22 21:16 UTC [SEC Form 4] [SEC Form 4: Smith Thomas B disposed of 52,530 shares, closing all direct ownership in the company (withholding obligation)](https://www.quantisnow.com/insight/sec-form-4-smith-thomas-b-disposed-of-52530-shares-2610830)
- 2022-03-22 21:15 UTC [SEC Form 4] [SEC Form 4: Sirgo Mark A disposed of 1,166,866 shares, closing all direct ownership in the company (for tax liability)](https://www.quantisnow.com/insight/sec-form-4-sirgo-mark-a-disposed-of-1166866-shares-2610819)
- 2022-03-22 21:14 UTC [SEC Form 4] [SEC Form 4: Plesha Scott M. disposed of 345,127 shares, closing all direct ownership in the company to satisfy withholding obligation](https://www.quantisnow.com/insight/sec-form-4-plesha-scott-m-disposed-of-345127-shares-2610804)
- 2022-03-22 21:14 UTC [SEC Form 4] [SEC Form 4: Kotler Kevin disposed of 7,588,395 shares](https://www.quantisnow.com/insight/sec-form-4-kotler-kevin-disposed-of-7588395-shares-2610796)
- 2022-03-22 21:13 UTC [SEC Form 4] [SEC Form 4 filed by Golubieski John to cover withholding tax](https://www.quantisnow.com/insight/sec-form-4-filed-by-golubieski-john-to-cover-withholding-2610784)
- 2022-03-22 21:12 UTC [SEC Form 4] [SEC Form 4: Greenleaf Peter disposed of 105,034 shares, closing all direct ownership in the company to cover withholding tax](https://www.quantisnow.com/insight/sec-form-4-greenleaf-peter-disposed-of-105034-shares-closing-2610775)
- 2022-03-22 21:12 UTC [SEC Form 4] [SEC Form 4: Davis Todd C disposed of 252,207 shares, closing all direct ownership in the company to satisfy withholding obligation](https://www.quantisnow.com/insight/sec-form-4-davis-todd-c-disposed-of-252207-shares-2610770)
- 2022-03-22 21:11 UTC [SEC Form 4] [SEC Form 4: Bailey Jeffrey Allen disposed of 105,133 shares, closing all direct ownership in the company to cover taxes](https://www.quantisnow.com/insight/sec-form-4-bailey-jeffrey-allen-disposed-of-105133-shares-2610766)
- 2022-03-22 21:09 UTC [SEC Form 8-K] [BioDelivery Sciences International Inc. filed SEC Form 8-K: Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control of Registrant, Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits](https://www.quantisnow.com/insight/biodelivery-sciences-international-inc-filed-sec-form-8-k-termination-of-2610741)
- 2022-03-22 21:01 UTC [Mergers & Acquisitions] [Collegium Completes the Acquisition of BDSI](https://www.quantisnow.com/insight/collegium-completes-the-acquisition-of-bdsi-2610624)
- 2022-03-21 11:07 UTC [SEC Schedule 14D-9] [SEC Form SC 14D9/A filed by BioDelivery Sciences International Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-14d9a-filed-by-biodelivery-sciences-international-inc-2599741)
- 2022-03-11 21:32 UTC [SEC Schedule 14D-9] [SEC Form SC 14D9/A filed by BioDelivery Sciences International Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-14d9a-filed-by-biodelivery-sciences-international-inc-2563656)
- 2022-03-11 13:08 UTC [SEC Form 4] [SEC Form 4: Bailey Jeffrey Allen converted options into 5,333 shares, increasing direct ownership by 5% to 105,133 units](https://www.quantisnow.com/insight/sec-form-4-bailey-jeffrey-allen-converted-options-into-5333-2560252)
- 2022-03-09 22:28 UTC [SEC Form 10-K] [SEC Form 10-K filed by BioDelivery Sciences International Inc.](https://www.quantisnow.com/insight/sec-form-10-k-filed-by-biodelivery-sciences-international-inc-2550580)
- 2022-03-04 13:41 UTC [SEC Schedule 14D-9] [SEC Form SC 14D9/A filed by BioDelivery Sciences International Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-14d9a-filed-by-biodelivery-sciences-international-inc-2523828)
- 2022-02-24 17:05 UTC [SEC Schedule 13D] [SEC Form SC 13D filed by BioDelivery Sciences International Inc.](https://www.quantisnow.com/insight/sec-form-sc-13d-filed-by-biodelivery-sciences-international-inc-2469394)
- 2022-02-24 16:06 UTC [SEC Schedule 13G] [SEC Form SC 13G filed by BioDelivery Sciences International Inc.](https://www.quantisnow.com/insight/sec-form-sc-13g-filed-by-biodelivery-sciences-international-inc-2468825)
- 2022-02-24 13:38 UTC [Market Insight] [BioDelivery Sciences Announces Availability Of ELYXYB In US For Acute Migraine](https://www.quantisnow.com/insight/biodelivery-sciences-announces-availability-of-elyxyb-in-us-for-acute-2467116)
- 2022-02-24 13:30 UTC [BioDelivery Sciences International Announces ELYXYB™ is Now Available in the U.S. for the Acute Treatment of Migraine](https://www.quantisnow.com/insight/biodelivery-sciences-international-announces-elyxyb-is-now-available-in-the-2466950)
- 2022-02-18 22:19 UTC [SEC Schedule 14D-9] [SEC Form SC 14D9 filed by BioDelivery Sciences International Inc.](https://www.quantisnow.com/insight/sec-form-sc-14d9-filed-by-biodelivery-sciences-international-inc-2444459)
- 2022-02-15 21:57 UTC [SEC Form SC14D9C filed by BioDelivery Sciences International Inc.](https://www.quantisnow.com/insight/sec-form-sc14d9c-filed-by-biodelivery-sciences-international-inc-2422860)
- 2022-02-15 21:54 UTC [SEC Form 8-K] [BioDelivery Sciences International Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Regulation FD Disclosure, Financial Statements and Exhibits (Amendment)](https://www.quantisnow.com/insight/biodelivery-sciences-international-inc-filed-sec-form-8-k-entry-into-2422833)
- 2022-02-15 21:30 UTC [SEC Form 4] [SEC Form 4: Kotler Kevin converted options into 2,422,222 shares](https://www.quantisnow.com/insight/sec-form-4-kotler-kevin-converted-options-into-2422222-shares-2422506)
- 2022-02-15 15:02 UTC [Market Insight] [Benzinga's Top Ratings Upgrades, Downgrades For February 15, 2022](https://www.quantisnow.com/insight/benzingas-top-ratings-upgrades-downgrades-for-february-15-2022-2419357)
- 2022-02-15 09:35 UTC [Analyst Downgrade] [BioDelivery Sciences Intl downgraded by Piper Sandler with a new price target](https://www.quantisnow.com/insight/biodelivery-sciences-intl-downgraded-by-piper-sandler-with-a-new-2416217)
- 2022-02-15 09:36 UTC [Market Chatter] [Piper Sandler Downgrades BioDelivery Sciences Intl to Neutral, Raises Price Target to $5.6](https://www.quantisnow.com/insight/piper-sandler-downgrades-biodelivery-sciences-intl-to-neutral-raises-price-2416216)
- 2022-02-15 09:32 UTC [Market Insight] [52 Biggest Movers From Yesterday](https://www.quantisnow.com/insight/52-biggest-movers-from-yesterday-2416211)
- 2022-02-14 21:59 UTC [SEC Form SC14D9C filed by BioDelivery Sciences International Inc.](https://www.quantisnow.com/insight/sec-form-sc14d9c-filed-by-biodelivery-sciences-international-inc-2414549)
- 2022-02-14 19:35 UTC [Market Insight] [Mid-Afternoon Market Update: Nasdaq Turns Lower; Dow Dips 350 Points](https://www.quantisnow.com/insight/mid-afternoon-market-update-nasdaq-turns-lower-dow-dips-350-points-2410641)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/BDSI
- Earnings history: https://www.quantisnow.com/earnings/BDSI
- Dividend history: https://www.quantisnow.com/dividends/BDSI
- Insider transactions: https://www.quantisnow.com/insiders/BDSI
- Options chain: https://www.quantisnow.com/options/BDSI
- SEC 8-K filings only: https://www.quantisnow.com/company/BDSI/8-k
- RSS and alerts for BDSI: https://www.quantisnow.com/docs/rss-feeds.md
